Connect with us

Hi, what are you looking for?

Jewish Business News

Business

Japanese Takeda Pharmaceuticals opens office In Israel

Takeda Israel Ltd. will be headquartered in the Tel Aviv area and will market products with an initial focus on oncology.
Takeda Pharmaceuticals

Takeda Pharmaceuticals International GmbH, headquartered in Zurich

Takeda Pharmaceuticals International GmbH (“Takeda”) today announced further expansion of its commercial platform with the establishment of its wholly-owned subsidiary in Israel. Together with Algeria,  Ecuador,  Peru,  Singapore and Vietnam, Israel is the sixth sales entity Takeda has opened this year to reinforce its platform in growth markets.

Takeda Israel LTD will be headquartered in the Tel Aviv area and will be responsible for the sales and marketing of selected products from Takeda’s portfolio and pipeline, with an initial focus on oncology. Takeda Israel will also seek local partners with complementary portfolios, through which to launch additional proven medicines from its current portfolio. Through its established network of local partners, Takeda products currently sold in Israel are Actos (pioglitazone), Atacand (candesartan), Contoloc (pantoprazole), Lucrin (leuroprelin), Xefo (lornoxicam), Mepact (mifamurtide) and other treatments in various therapeutic areas.

Israel is a highly developed pharma market with a universal healthcare system that values innovative medicines. The National Health Insurance constantly expands its list of reimbursable products, having dedicated more than a third of its additional funds over the last ten years to cancer treatment.

Takeda logo

According to Business Monitor International, pharmaceutical sales in Israel totaled US$ 1.5 billion in 2012 and are expected to grow at a compound annual rate of 6% between 2013 and 2017, driven by population growth and an increased need for specialty treatments. Takeda plans to outgrow the market over the same period.

Arie Kramer has been appointed Country Manager for Israel. He joins from AbbVie Biopharma, where he headed Finance and Strategic Commercial Planning. Previously he had served as General Manager, Chief Financial Officer and Operations Manager at Novartis Consumer Health in Israel.

There is a growing demand for specialty treatments in Israel,  said Arie Kramer, Country manager Takeda Israel. The establishment of our subsidiary demonstrates our commitment to bringing innovative new medicines to patients and will enable us to address some of the countrys current unmet healthcare needs.

Takeda is a global pharmaceutical company based in Japan that is poised to meet the challenges of the constantly evolving pharmaceutical market. For more than 230 years, Takeda has been committed to serving the global community through healthcare solutions from prevention to care to cure. Takeda is the largest pharmaceutical company in Japan and the 15thlargest in the world, with approximately 30, 000 employees in 70 countries. The Company’s mission is to strive toward better health for people worldwide through leading innovation in medicine.

Click to comment

Newsletter

Advertisement

You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...

Entertainment

The Movie The Professional is what made Natalie Portman a Lolita.

Travel

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.

Advertisement